SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Clinical trial NCT00331864 · COMPLETED
Trial details
- NCT number
- NCT00331864
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2008-04-01
- Enrollment
- 531
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.